Establishment Labs reported a strong third quarter in 2022, with worldwide sales reaching $38.2 million, a 31.7% increase year-over-year. The company has tightened its 2022 revenue guidance to a range of $158 million to $162 million, representing a 25% to 28% increase over 2021.
Third quarter worldwide sales reached $38.2 million, a 31.7% increase year-over-year.
Revenue guidance for 2022 tightened to a range of $158 million to $162 million, an increase of 25% to 28% over 2021.
Gross profit for the third quarter was 68.1% of revenue, compared to 67.6% for the same period in 2021.
Cash balance of $65.3 million as of September 30, 2022.
Establishment Labs expects strong financial results will continue into the fourth quarter and into 2023. The company is preparing for new opportunities, including launches of Motiva into the U.S. and China and the commercial introduction of Mia Femtech.
Analyze how earnings announcements historically affect stock price performance